Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fong Lok

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Journal of Viral Hepatitis|August 18, 2015
Hepatitis B: 50 years after the discovery of Australia antigenA Suk-Fong Lok
Hepatology (Baltimore, Md.)|February 1, 2006
Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005Hyung Joon Yim, Anna Suk-Fong Lok
Journal of Hepatology|February 20, 2003
Management of chronic hepatitis BHari S Conjeevaram, Anna Suk-Fong Lok
Journal of Hepatology|April 12, 2002
Clinical utility in quantifying serum HBV DNA levels using PCR assaysChi Jen Chu, Anna Suk-Fong Lok
Hepatology (Baltimore, Md.)|April 15, 2025
Accurate identification and risk-stratification of HBeAg-negative indeterminate phase of chronic hepatitis B: Not all shades of grey are the sameTai-Chung Tseng, Anna Suk-Fong Lok
Human Fertility (Cambridge, England)|July 19, 2003
Surgical intervention in infertility managementFong Lok, William L Ledger, Tin C Li
Clinics in Liver Disease|July 20, 2010
Antiviral therapy for chronic hepatitis BSyed-Mohammed R Jafri, Anna Suk-Fong Lok
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 26, 2019
How Do We Determine Whether a Functional Cure for HBV Infection Has Been Achieved?Terry Cheuk-Fung Yip, Anna Suk-Fong Lok
Hepatology (Baltimore, Md.)|November 13, 2019
Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints ConferenceMarkus Cornberg, Anna Suk-Fong Lok, Norah A Terrault, et al.
Journal of Hepatology|November 16, 2019
Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference<sup>‡</sup>Markus Cornberg, Anna Suk-Fong Lok, Norah A Terrault, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Journal of Viral Hepatitis|August 18, 2015
Hepatitis B: 50 years after the discovery of Australia antigenA Suk-Fong Lok
Hepatology (Baltimore, Md.)|February 1, 2006
Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005Hyung Joon Yim, Anna Suk-Fong Lok
Journal of Hepatology|February 20, 2003
Management of chronic hepatitis BHari S Conjeevaram, Anna Suk-Fong Lok
Journal of Hepatology|April 12, 2002
Clinical utility in quantifying serum HBV DNA levels using PCR assaysChi Jen Chu, Anna Suk-Fong Lok
Hepatology (Baltimore, Md.)|April 15, 2025
Accurate identification and risk-stratification of HBeAg-negative indeterminate phase of chronic hepatitis B: Not all shades of grey are the sameTai-Chung Tseng, Anna Suk-Fong Lok
Human Fertility (Cambridge, England)|July 19, 2003
Surgical intervention in infertility managementFong Lok, William L Ledger, Tin C Li
Clinics in Liver Disease|July 20, 2010
Antiviral therapy for chronic hepatitis BSyed-Mohammed R Jafri, Anna Suk-Fong Lok
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 26, 2019
How Do We Determine Whether a Functional Cure for HBV Infection Has Been Achieved?Terry Cheuk-Fung Yip, Anna Suk-Fong Lok
Hepatology (Baltimore, Md.)|November 13, 2019
Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints ConferenceMarkus Cornberg, Anna Suk-Fong Lok, Norah A Terrault, et al.
Journal of Hepatology|November 16, 2019
Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference<sup>‡</sup>Markus Cornberg, Anna Suk-Fong Lok, Norah A Terrault, et al.
Pageof 3